PATENT CLAIM ANALYSIS

Application Number: 15773659
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "093100"]

Abstract:
The present invention relates to the use of insulin-producing cells encapsulated in silanized hydroxypropyl methylcellulose (Si—HPMC) for the treatment of type 1 diabetes. Methods and kits are also provided for restoring and/or maintaining euglycemia in type 1 diabetic patients and in type 1 prediabetic patients.

Claim (Index 28):
The kit according to  claim 26 , wherein the insulin-producing cells are isolated allogenic pancreatic islets or isolated xenogenic pancreatic islets.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 93.0
- Lexical Diversity: 1.32432
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10684859', '11327074', '15317657', '14186973', '12121123']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7657315890458659
- 35 USC 102 Novelty (BERT): 0.5244328133828757
- Combined Prediction Score: 0.7416017114795669
- Mean Citation Score: 303.177832
- Max Citation Score: 318.23706
- Similarity Product: 193.0650738789224

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test